Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Theravance’s izencitinib fails in Phase IIb ulcerative colitis trial,

… drug candidate izencitinib (TD-1473) failed to meet the primary endpoint in Phase IIb dose-finding induction clinical trial to treat ulcerative colitis., … drug candidate izencitinib (TD-1473) failed to meet the primary endpoint in Phase IIb dose-finding induction clinical trial to treat ulcerative colitis., Read More

Scroll to Top